UPF3B and liver cancer: The results summarized in Fig 7B show that the high UPF3B expressing liver cancer patients had higher TME scores as compared to the subset of patients showing lower UPF3B expression (TMEscoreA, B, Immune Checkpoint and 12 related pathways score).